Lyme disease vaccine shows strong results. How it works. [USA TODAY]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: USA TODAY
Who told embassy staff to leave over Iran fears? AI Overview Full Summary Pfizer, together with Valenva, is pursuing FDA approval for a Lyme disease vaccine that demonstrated about 73% efficacy in trials, and the article explains how the vaccine works and the broader context of Lyme disease in the United States. Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness. Although fewer-than-expected cases in the study made it difficult to assess the vaccine's effectiveness on a large scale. When compared to a placebo, the vaccine showed a 73.2% efficacy rate against confirmed Lyme disease cases beginning 28 days following the fourth dosage. Pfizer is more confident "in the vaccine's potential" as it prepares "submissions to regulatory authorities" after a second planned analysis, the company said in a recent statement The Centers for Diseas
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better” [Yahoo! Finance]Yahoo! Finance
- Consecutive approvals of Opdivo for Hodgkin's lymphoma to boost sales growth [Yahoo! Finance]Yahoo! Finance
- ????????????? - ??????????????????2026-2035? [CNET News]CNET News
- Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data [Yahoo! Finance]Yahoo! Finance
- Income Investors Face a Hard Truth About Pfizer's Payout Safety [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/16/26 - Form 4
- 3/12/26 - Form ARS
- PFE's page on the SEC website